Please try another search
© Reuters. FILE PHOTO: Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India poses for a picture at the Serum Institute of India, Pune, India, 30 November 2020. Picture taken November 30, 2020. REUTERS/Francis Mascarenhas/File Photo
(Reuters) - Vaccine maker Serum Institute of India (SII) has pledged 50 million pounds ($66.2 million) to the University of Oxford for setting up a research campus that would also house the institute behind the AstraZeneca-Oxford COVID-19 shot.
The investment was made through the Indian company's Serum Life Sciences unit, Oxford University said on Wednesday. The research building would be named after Serum's billionaire owners, the Poonawalla family. The pledge builds on the collaboration between Oxford University, AstraZeneca (NASDAQ:AZN) and SII, the world's largest maker of vaccines and the producer of a version of the British duo's COVID-19 shot for low- and middle-income countries.
SII has also agreed with the Jenner Institute, which was behind the Oxford-AstraZeneca COVID-19 vaccine, to produce and develop Jenner's R21/Matrix-M malaria shot on a large scale. The shot is currently in late-stage trials.
SII was founded in 1966 in the Western Indian city of Pune by Cyrus Poonawalla, son of a horse breeder, and India's fifth-richest person, according to Forbes. In 2019, Cyrus was also conferred an honorary degree by Oxford University.
It is currently run by his son Adar Poonawalla, whose wife Natasha Poonawalla heads Serum Life Sciences. With a penchant for luxury cars and racehorses, the pair is often seen rubbing shoulders with Hollywood and Bollywood stars.
The Poonawallas in September invested 50 million pounds in Oxford Biomedica to help fund the development of a plant that manufactures COVID-19 shots.
($1 = 0.7559 pounds)
LONDON (Reuters) - Major Capricorn Energy investor Madison Avenue sees Capricorn's value at a minimum of 300 pence per share, above its value in a planned merger with Tullow Oil ...
The second-quarter reporting season is entering its final leg. The past week’s earnings were largely skewed to the negative side. Out of the S&P 500 companies that have...
The past weekend saw some activity in the crypto market, and it remains to be seen if the buoyancy spills over into their equity counterparts. As the major U.S. averages fight to...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.